F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Bevacizumab

Page 1 of 1 ( 38 items )
<<
1
>>

1	Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment 10/25/2024 10:27:31 AM \| Browse: 99 \| Download: 435
2	Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1 8/8/2024 4:58:16 AM \| Browse: 166 \| Download: 612
3	Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients 11/15/2022 10:19:35 AM \| Browse: 561 \| Download: 1960
4	Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review 7/14/2022 8:05:03 AM \| Browse: 630 \| Download: 1821
5	Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report 6/24/2022 9:00:24 AM \| Browse: 506 \| Download: 1447
6	Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice 9/22/2021 8:09:41 AM \| Browse: 626 \| Download: 977
7	Colorectal cancer metastatic to the breast: A case report 9/10/2020 5:57:28 AM \| Browse: 884 \| Download: 1666
8	Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report 7/20/2020 2:28:50 AM \| Browse: 887 \| Download: 2141
9	Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports 4/28/2020 8:04:31 AM \| Browse: 960 \| Download: 1695
10	Primary tumor location and survival in colorectal cancer: A retrospective cohort study 4/15/2020 12:00:00 PM \| Browse: 905 \| Download: 1888
11	Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy 2/22/2019 4:33:37 AM \| Browse: 1154 \| Download: 1378
12	Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review 1/16/2019 8:39:45 AM \| Browse: 964 \| Download: 1957
13	Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors 12/14/2018 10:51:23 AM \| Browse: 973 \| Download: 1401
14	CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer 11/13/2018 8:04:45 AM \| Browse: 1198 \| Download: 1932
15	Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia 12/20/2016 1:38:00 PM \| Browse: 1323 \| Download: 2297
16	Role of targeted therapy in metastatic colorectal cancer 9/12/2016 10:43:00 AM \| Browse: 1218 \| Download: 2087
17	Treatment of diabetic retinopathy: Recent advances and unresolved challenges 8/23/2016 8:55:00 AM \| Browse: 1242 \| Download: 2087
18	Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer 7/15/2016 3:38:00 PM \| Browse: 1390 \| Download: 2265
19	Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment 9/30/2015 4:28:00 PM \| Browse: 1460 \| Download: 2047
20	Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 6/20/2015 5:38:00 PM \| Browse: 1630 \| Download: 3202
21	Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab 5/13/2015 10:38:00 AM \| Browse: 1271 \| Download: 2685
22	Value of bevacizumab in treatment of colorectal cancer: A meta-analysis 4/27/2015 4:29:00 PM \| Browse: 1353 \| Download: 2022
23	Targeted therapy in first line treatment of RAS wild type colorectal cancer 3/16/2015 6:04:00 PM \| Browse: 1257 \| Download: 1715
24	FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma 2/11/2015 4:38:00 PM \| Browse: 1177 \| Download: 1342
25	Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status 11/19/2014 2:49:00 PM \| Browse: 1268 \| Download: 1602
26	Bevacizumab maintenance in metastatic colorectal cancer: How long? 11/10/2014 12:19:00 PM \| Browse: 1213 \| Download: 1767
27	Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy 10/20/2014 9:54:00 AM \| Browse: 1276 \| Download: 1938
28	Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases 9/16/2014 6:10:00 PM \| Browse: 1326 \| Download: 1290
29	Role of bevacizumab in colorectal cancer growth and its adverse effects: A review 9/15/2014 8:54:00 PM \| Browse: 1368 \| Download: 1414
30	Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives 9/11/2014 8:40:00 PM \| Browse: 1188 \| Download: 1714
31	Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012 9/3/2014 11:44:00 AM \| Browse: 1290 \| Download: 1727
32	Bevacizumab for the management of diabetic macular edema 9/1/2014 3:42:00 PM \| Browse: 1312 \| Download: 1279
33	Ranibizumab in diabetic macular edema 9/1/2014 2:50:00 PM \| Browse: 1284 \| Download: 1437
34	Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer 9/1/2014 10:30:00 AM \| Browse: 1469 \| Download: 1147
35	Targeting receptor tyrosine kinases in gastric cancer 8/28/2014 5:50:00 PM \| Browse: 1285 \| Download: 1509
36	Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review 8/26/2014 5:16:00 PM \| Browse: 1338 \| Download: 1138
37	Advances and new perspectives in the treatment of metastatic colon cancer 8/26/2014 4:37:00 PM \| Browse: 1376 \| Download: 1693
38	Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer 8/26/2014 4:36:00 PM \| Browse: 1362 \| Download: 1286

Page 1 of 1 ( 38 items )
<<
1
>>

1	Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment 10/25/2024 10:27:31 AM \| Browse: 99 \| Download: 435
2	Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1 8/8/2024 4:58:16 AM \| Browse: 166 \| Download: 612
3	Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients 11/15/2022 10:19:35 AM \| Browse: 561 \| Download: 1960
4	Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review 7/14/2022 8:05:03 AM \| Browse: 630 \| Download: 1821
5	Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report 6/24/2022 9:00:24 AM \| Browse: 506 \| Download: 1447
6	Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice 9/22/2021 8:09:41 AM \| Browse: 626 \| Download: 977
7	Colorectal cancer metastatic to the breast: A case report 9/10/2020 5:57:28 AM \| Browse: 884 \| Download: 1666
8	Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report 7/20/2020 2:28:50 AM \| Browse: 887 \| Download: 2141
9	Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports 4/28/2020 8:04:31 AM \| Browse: 960 \| Download: 1695
10	Primary tumor location and survival in colorectal cancer: A retrospective cohort study 4/15/2020 12:00:00 PM \| Browse: 905 \| Download: 1888
11	Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy 2/22/2019 4:33:37 AM \| Browse: 1154 \| Download: 1378
12	Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review 1/16/2019 8:39:45 AM \| Browse: 964 \| Download: 1957
13	Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors 12/14/2018 10:51:23 AM \| Browse: 973 \| Download: 1401
14	CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer 11/13/2018 8:04:45 AM \| Browse: 1198 \| Download: 1932
15	Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia 12/20/2016 1:38:00 PM \| Browse: 1323 \| Download: 2297
16	Role of targeted therapy in metastatic colorectal cancer 9/12/2016 10:43:00 AM \| Browse: 1218 \| Download: 2087
17	Treatment of diabetic retinopathy: Recent advances and unresolved challenges 8/23/2016 8:55:00 AM \| Browse: 1242 \| Download: 2087
18	Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer 7/15/2016 3:38:00 PM \| Browse: 1390 \| Download: 2265
19	Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment 9/30/2015 4:28:00 PM \| Browse: 1460 \| Download: 2047
20	Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 6/20/2015 5:38:00 PM \| Browse: 1630 \| Download: 3202
21	Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab 5/13/2015 10:38:00 AM \| Browse: 1271 \| Download: 2685
22	Value of bevacizumab in treatment of colorectal cancer: A meta-analysis 4/27/2015 4:29:00 PM \| Browse: 1353 \| Download: 2022
23	Targeted therapy in first line treatment of RAS wild type colorectal cancer 3/16/2015 6:04:00 PM \| Browse: 1257 \| Download: 1715
24	FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma 2/11/2015 4:38:00 PM \| Browse: 1177 \| Download: 1342
25	Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status 11/19/2014 2:49:00 PM \| Browse: 1268 \| Download: 1602
26	Bevacizumab maintenance in metastatic colorectal cancer: How long? 11/10/2014 12:19:00 PM \| Browse: 1213 \| Download: 1767
27	Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy 10/20/2014 9:54:00 AM \| Browse: 1276 \| Download: 1938
28	Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases 9/16/2014 6:10:00 PM \| Browse: 1326 \| Download: 1290
29	Role of bevacizumab in colorectal cancer growth and its adverse effects: A review 9/15/2014 8:54:00 PM \| Browse: 1368 \| Download: 1414
30	Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives 9/11/2014 8:40:00 PM \| Browse: 1188 \| Download: 1714
31	Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012 9/3/2014 11:44:00 AM \| Browse: 1290 \| Download: 1727
32	Bevacizumab for the management of diabetic macular edema 9/1/2014 3:42:00 PM \| Browse: 1312 \| Download: 1279
33	Ranibizumab in diabetic macular edema 9/1/2014 2:50:00 PM \| Browse: 1284 \| Download: 1437
34	Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer 9/1/2014 10:30:00 AM \| Browse: 1469 \| Download: 1147
35	Targeting receptor tyrosine kinases in gastric cancer 8/28/2014 5:50:00 PM \| Browse: 1285 \| Download: 1509
36	Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review 8/26/2014 5:16:00 PM \| Browse: 1338 \| Download: 1138
37	Advances and new perspectives in the treatment of metastatic colon cancer 8/26/2014 4:37:00 PM \| Browse: 1376 \| Download: 1693
38	Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer 8/26/2014 4:36:00 PM \| Browse: 1362 \| Download: 1286